These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37897141)

  • 1. Gastric inhibitory polypeptide receptor antagonism suppresses intramuscular adipose tissue accumulation and ameliorates sarcopenia.
    Takahashi Y; Fujita H; Seino Y; Hattori S; Hidaka S; Miyakawa T; Suzuki A; Waki H; Yabe D; Seino Y; Yamada Y
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2703-2718. PubMed ID: 37897141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle Regeneration with Intermuscular Adipose Tissue (IMAT) Accumulation Is Modulated by Mechanical Constraints.
    Pagano AF; Demangel R; Brioche T; Jublanc E; Bertrand-Gaday C; Candau R; Dechesne CA; Dani C; Bonnieu A; Py G; Chopard A
    PLoS One; 2015; 10(12):e0144230. PubMed ID: 26629696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.
    Malavazos AE; Iacobellis G; Dozio E; Basilico S; Di Vincenzo A; Dubini C; Menicanti L; Vianello E; Meregalli C; Ruocco C; Ragni M; Secchi F; Spagnolo P; Castelvecchio S; Morricone L; Buscemi S; Giordano A; Goldberger JJ; Carruba M; Cinti S; Corsi Romanelli MM; Nisoli E
    Eur J Prev Cardiol; 2023 Jun; 30(8):680-693. PubMed ID: 36799940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle.
    Hosoyama T; Kawai-Takaishi M; Iida H; Yamamoto Y; Nakamichi Y; Watanabe T; Takemura M; Kato S; Uezumi A; Matsui Y
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):907-918. PubMed ID: 38533539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibro-adipogenic progenitors in physiological adipogenesis and intermuscular adipose tissue remodeling.
    Flores-Opazo M; Kopinke D; Helmbacher F; Fernández-Verdejo R; Tuñón-Suárez M; Lynch GS; Contreras O
    Mol Aspects Med; 2024 Jun; 97():101277. PubMed ID: 38788527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pim1 knockout alleviates sarcopenia in aging mice via reducing adipogenic differentiation of PDGFRα
    Shang GK; Han L; Wang ZH; Song M; Wang D; Tan YM; Li YH; Li YL; Zhang W; Zhong M
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1741-1756. PubMed ID: 34435457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling protein 1 expression in adipocytes derived from skeletal muscle fibro/adipogenic progenitors is under genetic and hormonal control.
    Gorski T; Mathes S; Krützfeldt J
    J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):384-399. PubMed ID: 29399988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term disuse promotes fatty acid infiltration into skeletal muscle.
    Pagano AF; Brioche T; Arc-Chagnaud C; Demangel R; Chopard A; Py G
    J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):335-347. PubMed ID: 29248005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
    Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
    J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
    Mroz PA; Finan B; Gelfanov V; Yang B; Tschöp MH; DiMarchi RD; Perez-Tilve D
    Mol Metab; 2019 Feb; 20():51-62. PubMed ID: 30578168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
    Boer GA; Keenan SN; Miotto PM; Holst JJ; Watt MJ
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E835-E845. PubMed ID: 33645252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique sarcopenic progression in the mouse rotator cuff.
    Meyer GA; Shen KC
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):561-573. PubMed ID: 34708577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human GIP(3-30)NH
    Gabe MBN; Sparre-Ulrich AH; Pedersen MF; Gasbjerg LS; Inoue A; Bräuner-Osborne H; Hartmann B; Rosenkilde MM
    Biochem Pharmacol; 2018 Apr; 150():97-107. PubMed ID: 29378179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms.
    Campbell JE
    Mol Metab; 2021 Apr; 46():101139. PubMed ID: 33290902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of GIP signaling extends lifespan without caloric restriction.
    Hoizumi M; Sato T; Shimizu T; Kato S; Tsukiyama K; Narita T; Fujita H; Morii T; Sassa MH; Seino Y; Yamada Y
    Biochem Biophys Res Commun; 2019 Jun; 513(4):974-982. PubMed ID: 31003779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased GIP signaling induces adipose inflammation via a HIF-1α-dependent pathway and impairs insulin sensitivity in mice.
    Chen S; Okahara F; Osaki N; Shimotoyodome A
    Am J Physiol Endocrinol Metab; 2015 Mar; 308(5):E414-25. PubMed ID: 25537494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of skeletal muscle atrophy and intermuscular adipose tissue in patients with early breast cancer treated with chemotherapy.
    Mallard J; Hucteau E; Bender L; Charlot A; Debrut L; Pflumio C; Trensz P; Schott R; Favret F; Pivot X; Hureau TJ; Pagano AF
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1325-C1332. PubMed ID: 36094434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids increase adipocytes in muscle by affecting IL-4 regulated FAP activity.
    Dong Y; Silva KA; Dong Y; Zhang L
    FASEB J; 2014 Sep; 28(9):4123-32. PubMed ID: 24948596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.
    Ravn P; Madhurantakam C; Kunze S; Matthews E; Priest C; O'Brien S; Collinson A; Papworth M; Fritsch-Fredin M; Jermutus L; Benthem L; Gruetter M; Jackson RH
    J Biol Chem; 2013 Jul; 288(27):19760-72. PubMed ID: 23689510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism.
    Killion EA; Chen M; Falsey JR; Sivits G; Hager T; Atangan L; Helmering J; Lee J; Li H; Wu B; Cheng Y; Véniant MM; Lloyd DJ
    Nat Commun; 2020 Oct; 11(1):4981. PubMed ID: 33020469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.